{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T09:29:46Z","timestamp":1778059786892,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.braindev.2024.104317","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T07:52:12Z","timestamp":1736322732000},"page":"104317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevention of chronic pneumonia in children with severe motor and intellectual disabilities by long-term tobramycin inhalation: Its benefits and limitations"],"prefix":"10.1016","volume":"47","author":[{"given":"Yoshiaki","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Omae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Saiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chika","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Tamasaki-Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Maegaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensaku","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2024.104317_bb0005","first-page":"476","article-title":"Cause-of-death analysis based on age at death in patients with severe motor and intellectual disabilities syndrome","volume":"56","author":"Origuchi","year":"2002","journal-title":"IRYO"},{"key":"10.1016\/j.braindev.2024.104317_bb0010","first-page":"407","article-title":"Study of death with the severely disabled","volume":"48","author":"Onoe","year":"2016","journal-title":"No to Hattatsu"},{"key":"10.1016\/j.braindev.2024.104317_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijporl.2021.110665","article-title":"The effect of nebulized antibiotics in children with tracheostomy","volume":"143","author":"Atag","year":"2021","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.braindev.2024.104317_bb0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis","volume":"340","author":"Ramsey","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.braindev.2024.104317_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1378\/chest.121.1.55","article-title":"Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis","volume":"121","author":"Moss","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.braindev.2024.104317_bb0030","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/resp.13043","article-title":"The microbiome and secondary lung disease in neuromuscular patients is it time to change our clinical practice?","volume":"22","author":"Crescimanno","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.braindev.2024.104317_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.633039","article-title":"Inhaled antibiotics for the prevention of respiratory tract infections in children with a tracheostomy","volume":"9","author":"Jutras","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.braindev.2024.104317_bb0040","first-page":"155","article-title":"Nebulized tobramycin prevention of pneumonias in patients with severe cerebral palsy","volume":"4","author":"Plioplys","year":"2011","journal-title":"J Pediatr Rehabil Med"},{"key":"10.1016\/j.braindev.2024.104317_bb0045","first-page":"121","article-title":"Three severely disabled patients with recurrent Pseudomonas aeruginosa pneumonia who were successfully treated with nebulized tobramycin","volume":"41","author":"Miyake","year":"2016","journal-title":"J Severe Motor Intellect Disabil"},{"key":"10.1016\/j.braindev.2024.104317_bb0050","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00149-2018","article-title":"Reducing the frequency of respiratory tract infections in severe neurological disorders by inhaled antibiotics a retrospective data analysis","author":"Eckerland","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.braindev.2024.104317_bb0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1517\/14656566.2012.656090","article-title":"Tobramycin for the treatment of bacterial pneumonia in children","volume":"13","author":"Bothra","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.braindev.2024.104317_bb0060","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.braindev.2024.104317_bb0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12866-020-01785-9","article-title":"Extensively drug-resistant Haemophilus influenzae - emergence, epidemiology, risk factors, and regimen","volume":"20","author":"Su","year":"2020","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.braindev.2024.104317_bb0070","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.2147\/IDR.S376328","article-title":"In vitro studies of non-diphtheriae corynebacterium isolates on antimicrobial susceptibilities, drug resistance mechanisms, and biofilm formation capabilities","volume":"15","author":"Sun","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.braindev.2024.104317_bb0075","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.braindev.2024.104317_bb0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0029-1243626","article-title":"Fulminant sepsis-associated encephalopathy in two children serial neuroimaging findings and clinical course","volume":"40","author":"Kondo","year":"2009","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.braindev.2024.104317_bb0085","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/ppul.23716","article-title":"Pseudomonas aeruginosa and post-tracheotomy bacterial respiratory tract infection readmissions","volume":"52","author":"Russell","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.braindev.2024.104317_bb0090","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/ppul.24071","article-title":"Tracheostomy in children epidemiology and clinical outcomes","volume":"53","author":"Sanders","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.braindev.2024.104317_bb0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcf.2013.09.002","article-title":"Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis","volume":"13","author":"Stanojevic","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.braindev.2024.104317_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10096-015-2509-4","article-title":"Chronic infection phenotypes of Pseudomonas aeruginosa are associated with failure of eradication in children with cystic fibrosis","volume":"35","author":"Vidya","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.braindev.2024.104317_bb0105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcf.2018.04.002","article-title":"Eradication of early P. aeruginosa infection in children <7\u00a0years of age with cystic fibrosis the early study","volume":"18","author":"Ratjen","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.braindev.2024.104317_bb0110","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/thx.2009.121657","article-title":"Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis the ELITE trial","volume":"65","author":"Ratjen","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.braindev.2024.104317_bb0115","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3390\/antibiotics10050486","article-title":"Treatment of pulmonary disease of cystic fibrosis a comprehensive review","volume":"10","author":"Gir\u00f3n Moreno","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.braindev.2024.104317_bb0120","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcf.2020.02.015","article-title":"Cystic fibrosis foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease","volume":"19","author":"Kapnadak","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.braindev.2024.104317_bb0125","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/ppul.26288","article-title":"Inhaled antibiotics in children with tracheostomy tubes a descriptive study","volume":"58","author":"Gipsman","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.braindev.2024.104317_bb0130","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1378\/chest.06-2888","article-title":"Incidence and risk factors for multiple antibiotic-resistant pseudomonas aeruginosa in cystic fibrosis","volume":"132","author":"Merlo","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.braindev.2024.104317_bb0135","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jcf.2017.11.019","article-title":"Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics a longitudinal study using UK patient registry data","volume":"17","author":"Keogh","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"10","key":"10.1016\/j.braindev.2024.104317_bb0140","article-title":"Non-pharmaceutical management of respiratory morbidity in children with severe global developmental delay","volume":"2014","author":"Winfield","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.braindev.2024.104317_bb0145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fped.2020.00333","article-title":"Evaluation and management of respiratory illness in children with cerebral palsy","volume":"8","author":"Marpole","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.braindev.2024.104317_bb0150","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.rmed.2018.01.012","article-title":"Airway clearance techniques in neuromuscular disorders a state of the art review","volume":"136","author":"Chatwin","year":"2018","journal-title":"Respir Med"},{"issue":"Suppl. 1","key":"10.1016\/j.braindev.2024.104317_bb0155","first-page":"S22","article-title":"BTS clinical statement on the prevention and management of community-acquired pneumonia in people with learning disability","volume":"78","author":"Legg","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.braindev.2024.104317_bb0160","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/dmcn.14640","article-title":"Prevention and management of respiratory disease in young people with cerebral palsy consensus statement","volume":"63","author":"Gibson","year":"2021","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2024.104317_bb0165","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/dmcn.14060","article-title":"Respiratory morbidity in children with cerebral palsy an overview","volume":"61","author":"Boel","year":"2019","journal-title":"Dev Med Child Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.braindev.2024.104317_bb0170","doi-asserted-by":"crossref","first-page":"s3","DOI":"10.1136\/thorax-2022-219699","article-title":"BTS clinical statement on aspiration pneumonia","volume":"78","author":"Simpson","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.braindev.2024.104317_bb0175","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000488667","article-title":"On behalf of the guideline commission. German national guideline for treating chronic respiratory failure with invasive and non-invasive ventilation - revised edition 2017 Part 2","volume":"96","author":"Windisch","year":"2018","journal-title":"Respiration"},{"key":"10.1016\/j.braindev.2024.104317_bb0180","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1164\/rccm.201602-0276ST","article-title":"ATS pediatric chronic home ventilation workgroup. An official American Thoracic Society clinical practice guideline pediatric chronic home invasive ventilation","volume":"193","author":"Sterni","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.braindev.2024.104317_bb0185","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jcf.2024.04.004","article-title":"Update on the diagnosis and management of cystic fibrosis pulmonary exacerbations","volume":"23","author":"Cogen","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.braindev.2024.104317_bb0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00007691-198901000-00022","article-title":"Interpretation of excessive levels of inhaled tobramycin","volume":"11","author":"Bentur","year":"1989","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.braindev.2024.104317_bb0195","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijantimicag.2015.03.001","article-title":"Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii mechanisms and epidemiology","volume":"45","author":"Potron","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.braindev.2024.104317_bb0200","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/315312","article-title":"Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment","volume":"181","author":"MacLeod","year":"2000","journal-title":"J Infect Dis"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760424001700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760424001700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:04:34Z","timestamp":1762308274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760424001700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0387760424001700"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2024.104317","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of chronic pneumonia in children with severe motor and intellectual disabilities by long-term tobramycin inhalation: Its benefits and limitations","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2024.104317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society of Child Neurology. Elsevier B.V. CC BY-NC-ND 4.0","name":"copyright","label":"Copyright"}],"article-number":"104317"}}